Estimating Health and Economic Benefits from Using Prescription Omega-3 Fatty Acids in Patients With Severe Hypertriglyceridemia
To access this article, please choose from the options below
Funding for this study was provided by GlaxoSmithKline, Inc., Philadelphia, Pennsylvania.
PII: S0002-9149(11)01603-1
doi:10.1016/j.amjcard.2011.04.019
© 2011 Elsevier Inc. All rights reserved.
